<SEC-DOCUMENT>0001213900-18-005535.txt : 20180504
<SEC-HEADER>0001213900-18-005535.hdr.sgml : 20180504
<ACCEPTANCE-DATETIME>20180504161519
ACCESSION NUMBER:		0001213900-18-005535
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20180502
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180504
DATE AS OF CHANGE:		20180504

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OptimizeRx Corp
		CENTRAL INDEX KEY:			0001448431
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		IRS NUMBER:				261265381
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-53605
		FILM NUMBER:		18808102

	BUSINESS ADDRESS:	
		STREET 1:		400 WATER ST., STE. 200
		CITY:			ROCHESTER
		STATE:			MI
		ZIP:			48307
		BUSINESS PHONE:		248-651-6558

	MAIL ADDRESS:	
		STREET 1:		400 WATER ST., STE. 200
		CITY:			ROCHESTER
		STATE:			MI
		ZIP:			48307
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k050218_optimizerxcorp.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WASHINGTON, D.C. 20549<BR>
____________________</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO SECTION 13 OR 15(d) OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE SECURITIES EXCHANGE ACT OF 1934</B><BR>
<BR>
Date of Report (Date of earliest event reported): May 2, 2018<BR>
<BR>
<U>OptimizeRx Corporation</U><BR>
(Exact name of registrant as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-decoration: none">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; text-decoration: none">
<TR STYLE="vertical-align: top; text-decoration: none">
    <TD STYLE="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; text-decoration: none; border-bottom: Black 1.5pt solid">Nevada</TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; text-decoration: none; border-bottom: Black 1.5pt solid">000-53605</TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; text-decoration: none; border-bottom: Black 1.5pt solid">26-1265381</TD></TR>
<TR STYLE="vertical-align: top; text-decoration: none">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; text-decoration: none">(State or other jurisdiction <BR>
of incorporation)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; text-decoration: none">(Commission File Number)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; text-decoration: none">(I.R.S. Employer <BR>
Identification No.)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-decoration: none">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; text-decoration: none">
<TR STYLE="vertical-align: top; text-decoration: none">
    <TD STYLE="width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; text-decoration: none; border-bottom: Black 1.5pt solid">400 Water Street, Suite 200, Rochester,
    MI</TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; text-decoration: none; border-bottom: Black 1.5pt solid">48307</TD></TR>
<TR STYLE="vertical-align: top; text-decoration: none">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; text-decoration: none">(Address of principal executive offices)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; text-decoration: none">(Zip Code)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-decoration: none">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; text-decoration: none">Registrant&rsquo;s telephone number,
including area code: 248.651.6568</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">___________________________________________________</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed
        since last report)</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding: 0; text-align: left; text-indent: 0">&#9744;</TD>
    <TD STYLE="width: 96%; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&#9744;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&#9744;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&#9744;</TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (&sect;240.12b-2 of this chapter).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company&nbsp;&nbsp;&nbsp;&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Section 8 &ndash; Other Events</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 8.01 Other Events</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 2, 2018, the Company held a conference
call to discuss the Company&rsquo;s 2018 first quarter earnings and other matters of business, a transcript of which is furnished
herewith as Exhibit 99.1 and is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information in Item 8.01 of this Current
Report on Form 8-K (including Exhibit 99.1) shall not be deemed &ldquo;filed&rdquo; for purposes of Section 18 of the Securities
Exchange Act of 1934 (the &ldquo;Exchange Act&rdquo;) or otherwise subject to the liabilities of that section, nor shall it be
deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth
by specific reference in such a filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Section 9 &ndash; Financial Statements and Exhibits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 9.01 Financial Statements and Exhibits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 0.5in">99.1 </TD>
    <TD><A HREF="f8k050218ex99-1_optimizerx.htm">Conference call transcript dated May 2, 2018</A></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; text-decoration: none">
<TR STYLE="vertical-align: top; text-decoration: none">
    <TD STYLE="padding-top: 0; padding-right: 0; padding-left: 0; text-indent: 0; text-decoration: none"><B>OptimizeRx Corporation</B></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-decoration: none">
    <TD STYLE="padding-top: 0; padding-right: 0; padding-left: 0; text-indent: 0; text-decoration: none">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-decoration: none">
    <TD STYLE="width: 40%; padding: 0; text-indent: 0; text-decoration: none; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/
    Doug Baker</FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-decoration: none">
    <TD STYLE="padding: 0; text-indent: 0; text-decoration: none">Doug Baker<BR>
    Chief Financial Officer</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-decoration: none">
    <TD STYLE="padding: 0; text-indent: 0; text-decoration: none">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-decoration: none">
    <TD STYLE="padding: 0; text-indent: 0; text-decoration: none"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date:
    May 4, 2018</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>f8k050218ex99-1_optimizerx.htm
<DESCRIPTION>CONFERENCE CALL TRANSCRIPT DATED MAY 2, 2018
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="margin: 0; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="eximg_001.jpg" ALT=""><B>&nbsp;</B></FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-right: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><IMG SRC="eximg_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C
O R P O R A T E &nbsp;&nbsp;P A R T I C I P A N T S</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo, </B><I>Chief Executive Officer &amp; Director</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Douglas
Baker, </B><I>Chief Financial Officer</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Miriam
Paramore, </B><I>President</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C
O N F E R E N C E &nbsp;&nbsp;C A L L &nbsp;&nbsp;P A R T I C I P A N T S</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Eric
Martinuzzi, </B><I>Lake Street Capital Markets</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Andrew
D'Silva, </B><I>B. Riley FBR, Inc.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Harvey
Poppel, </B><I>Poptech, LP</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ron
Chez, </B><I>Private Investor</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>P
R E S E N T A T I O N</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Operator:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Good
afternoon, and thank you for joining us today to discuss OptimizeRx first quarter ended March 31, 2018. With us are the Company's
Chief Executive Officer, Will Febbo; the Company's President, Miriam Paramore; and its Chief Financial Officer, Doug Baker. Following
their remarks, we will open the call to your questions. Then before we conclude today's call, I'll provide some important cautions
regarding the forward-looking statements made by Management during the call.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I'd
also like to remind everyone that today's call is being recorded and will be made available for telephone replay via instructions
in today's press release in the Investors section of the Company's website.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Now,
I would like to turn the call over to OptimizeRx CEO, Will Febbo. Please go ahead, sir.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thank
you very much, Rebecca (phon), and good afternoon, everyone, and thanks for joining us on the call today. As you've now seen by
today's earnings release, we've been busy. On the call today, we&rsquo;d would like to talk about the strong progress we've been
making and the foundation we continue to lay in preparation for future growth and expansion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">1-888-562-0262 &nbsp;&nbsp;&nbsp;1-604-929-1352&nbsp;&nbsp;&nbsp;&nbsp; <U>www.viavid.com</U>&nbsp;</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><IMG SRC="eximg_002.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
strong growth is apparent by the numbers, I'd say on pretty much every level, but there is a lot more to communicate on top of
that, commercially, structurally and strategically, that is, without giving too much away. Let's start commercially. We've continued
to acquire new pharmaceutical brands and grow our existing customers on our core messaging platform. We've continued to expand
our distribution network of the electronic health record vendors, e-prescribe vendors and now clinical decision support vendors
as well.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Today,
our network reaches over half the nation's healthcare providers, or HCPs, you'll hear commonly, in the ambulatory market, making
OptimizeRx, the health care industry's largest point of care network. We deliver real-time financial assistance and critical clinical
information, from pharma companies to HCPs and patients. Our team is doing a tremendous job and our clients are thrilled with
our solutions, service and our culture.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Now,
structurally. As I have mentioned on past calls, when we felt confident, we had the momentum on all levels, we would bring OPRX
onto a major exchange and seek additional capital to support growth across all aspects of our business. In this regard, we've
done three key things. First, we announced today a private placement of $9 million with institutional investors who are as excited
about our prospects as we are.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second,
we received the approval of our Board for a reverse stock split of one-for-three, in order to meet the minimum price requirements
for NASDAQ. The current expectation is that we uplist within the next couple of months.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finally,
we added two new independent Board members that we announced last week and established a new audit committee, which will help
to share strong corporate governance as we scale the business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Now,
in terms of strategy. We have added clinical decision support as yet another channel through which we can reach doctors and help
patients better afford their medications. Later, Miriam will speak to clinical decision support and our recent announcement about
evidence care.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
is important because we started the process of reaching doctors and hospitals, a strategic comparative to scale. We also invested
in our data warehouse, reporting and analytics, as well as compliance and security. We're also proud to report our sixth consecutive
quarter of top line growth with revenue up 91% over the same year-ago period, driven by strong growth in all our messaging products
as well as brand support.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
sequential quarterly revenue growth also means we buck the traditional seasonal Q1 downtick. That's a big accomplishment and hats
off to the operational team there. Gross margin also improved from 35% Q1 of '17 to 51% this quarter due to greater volumes of
messagings across our platform and more favorable contract terms with our partners. Clearly, we are realizing the growth opportunity
in the digital health messaging marketplace, which by most measures, as I walked through on our last call, is plenty big to continue
growth at impressive levels.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
breadth of solutions and brands we offer our network, our extensive relationships with pharmaceutical companies, major EHRs and
the vast reach of our network, all work together to provide us a substantial competitive advantage and a dominant position in
the marketplace. I think we are starting to see this reflected in our valuation as well.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Now,
before we dive further into operational details from the first quarter and outlook for the remainder of the year, I'd like to
turn the call over to our CFO, Doug Baker, who will walk us through the financials for Q1. Doug?</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">1-888-562-0262 &nbsp;&nbsp;&nbsp;1-604-929-1352&nbsp;&nbsp;&nbsp;&nbsp; <U>www.viavid.com</U>&nbsp;</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><IMG SRC="eximg_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Douglas
Baker:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thanks,
Will, and good afternoon, everyone. Prior to the call, we issued a press release with the results of our first quarter ended March
31, 2018. A copy of that release is available on the Investor Relations section of our website. We reported net revenue in the
first quarter of 2018 increased 91% over the year-ago quarter to a record $4.1 million. The increase is primarily due to revenue
from our two core products of financial and brand messaging, coupled with broader distribution with our new channel partners.
The launch of new pharmaceutical brands also contributed to the increase.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically,
people ask about the actual number of brands we represent, but we've moved away from this metric because it doesn't necessarily
correlate directly to revenue. For example, one brand may generate over $1 million in revenue for us, while another more specialized
brand may be under $100,000. Also, as Will mentioned, historically there's been some seasonality in our business, where typically
the first quarter is sequentially down from the prior fourth quarter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
in this year's Q1, net revenue was up more than 2.6%, sequentially. Our sales force did a great job of getting 2018 projects locked
down in December, and our account managers and ops team did a great job pushing primer to move more quickly and getting things
launched in January.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
strong first quarter also increased our gross margin to 51.2% as compared to 35.8% in Q1 of last year. This big improvement was
due primarily to an increase in brand messaging revenues, which have a large fixed cause component to them.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
plan to continue to improve margins even further, targeting gross margins of at least 55% by the fourth quarter of this year.
Our operating expenses in the first quarter of 2018 were $2.3 million, up from $1.7 million in the same year-ago quarter. This
increase was mostly due to additional expenses related to growth initiatives, including expanding our executive and sales team.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
it is important to note that our operating expenses as a percentage of revenue declined to 56% as compared to 77% in the same
year-ago quarter. We expect our operating cost levels to remain at similar levels or only slightly increase for the balance of
2018. Our net loss for the first quarter of 2018 totaled $189,000 or $0.01 per share as compared to a net loss of $883,000 or
$0.03 per share in the year-ago quarter. The improvement in net loss was primarily due to the increase in revenues and the decrease
in operating expense, as a percentage of revenue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also,
I should note that a good portion of loss was attributed to noncash expenses. For example, excluding noncash expenses in the first
quarter of 2018, we would have had a net income of 300&mdash;of over $300,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Now,
turning to the balance sheet. Cash and cash equivalents totaled $4.3 million at March 31, 2018. This compares to $5.1 million
at December 31, 2017. The decrease in cash was due to the use of cash in operating activities, primarily a reduction in revenue
share payable, most of which resulted from a one-time change in payment terms with one of our partners. We expect to have continued
positive cash flow from operations in future quarters in 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we continue to operate debt-free. Following completion of our recently announced equity raise, we estimate our total
cash balance to be approximately $12.5 million and we will have approximately 34.6 million common shares outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That
wraps up our financial results. Now I'd like to turn the call over to Miriam.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">1-888-562-0262 &nbsp;&nbsp;&nbsp;1-604-929-1352&nbsp;&nbsp;&nbsp;&nbsp; <U>www.viavid.com</U>&nbsp;</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><IMG SRC="eximg_002.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT><B>Miriam
Paramore:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thanks,
Doug. I'm excited to talk about our recently announced partnership with EvidenceCare. It represents a major milestone for OptimizeRx,
as it expands our digital messaging beyond the ambulatory setting or office setting and into hospitals for the first time. This
partnership is unique for us in that it provides three firsts. It's our first messaging into the hospital workflow; it's our first
integration with a clinical decision support tool; and for the first time, it gives us the ability to integrate with those industry-leading
EHR vendors that have the strong presence or strongest presence in the hospital space.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Together
with EvidenceCare and these leading EHRs, we can increase the likelihood that healthcare providers, particularly those working
in a demanding and fast-paced hospital setting, select the best medication for their patients. We can also help more patients
save money and be better educated about their prescriptions. Unlike any other tool in the market, EvidenceCare provides clinicians
with access to reliable, evidence-based treatment recommendations at the bedside and in as little as 30 seconds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
was designed by physicians and curated by leading physician experts and medical societies, with patient-specific protocols made
available to healthcare providers via a web-based app that is integrated with the EHR and streamlines workflows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also,
EvidenceCare is led by experienced health care leaders who have strong industry relationships. We believe this represents not
only a major advancement in our point of care network expansion but also in the delivery of superior health care in the hospital
setting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Now
to turn for a moment to the enhancing of our technology infrastructure. We recently migrated our systems to the AWS cloud and
we solidified our use of industry-best practices for processing real-time data in a HIPAA compliance and secure manner.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also built a data warehouse to facilitate new reporting and data analytic capabilities that help us to provide valuable insights
to our customers. These changes will support our future growth and significantly enhance our value proposition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Now
with that, I'd like to turn the call back over to Will.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thanks,
Mariam, and thanks, Doug. Nice work. One of the key things our Q1 results demonstrate, in my opinion, is the substantial leverage
we're enjoying on our operating model. That is, how it supports greater market reach and revenue growth without lockstep increase
in operating cost. We've been saying it and now we're doing it. This means as we grow, we expect our operating expense as a percentage
of revenue to continue to decrease as our cash flow from operations strengthen.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
Doug mentioned, we expect our actual operating expenses throughout the rest of the year to continue at the Q1 2018 level or perhaps
slightly above as we further implement our business plan and expand our operations to grow the business in a very dramatic and
active marketplace. This effort will be supported by our strength and ability to acquire, integrate and expand the new promotional
EHR and eRx platforms. In fact, we expect to launch within seven EHRs in just '18 alone.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result, we have more master service agreements now than ever and we anticipate revenue from these channels to accelerate in
2018. I should also mention that we continue to report strong return on investment for our clients on current brands. The average
return on investment remained at a strong 5:1 ratio. We actually had one which was greater than 15:1 or let's just say, that client
is content and is growing their spend with OptimizeRx. This compelling ROI data is also encouraging the adoption of our cloud-based
EHR channels by potential clients. In terms of our existing client reach, we now work with all the top 20 manufacturers, all the
leading agencies that advise them on their marketing spend and several more of the top 50 manufacturers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">1-888-562-0262 &nbsp;&nbsp;&nbsp;1-604-929-1352&nbsp;&nbsp;&nbsp;&nbsp; <U>www.viavid.com</U>&nbsp;</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><IMG SRC="eximg_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
healthcare providers, the doctors, our platform solves major pain points by eliminating the need to manage and store physical
drug samples. HCPs can also spend less time dealing with pharma sales reps. We solve these challenges, which have resulted in
nearly 60% of doctors' offices banning or severely limiting access by pharma reps and the samples they offer. We offer healthcare
providers a far more convenient and efficient way to allocate, administer and track co-pay savings for their patients. They also
gain access to important clinical information, right within their workflow.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
EHR, which doctors now use over five hours a day, we have been reopening the door of critical communication between the doctor
and pharmaceutical companies in a way that benefits all stakeholders. Through this digital portal, pharma companies also regain
critical access to doctors and their patients. They can provide the prescription information and savings precisely when and where
the doctor needs it at point of care, which is leading to better health care outcomes with the medications prescribed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of our preparation for future growth, in the first quarter we appointed Patrick Spangler and Bryan Archambault on our Board
of Directors. These appointments reflect our plan to scale our business and further enhance our product offering. We believe Patrick's
background and experience, particularly as CFO of the electronic health record Company, Healthland and Epocrates, when it was
public and sold to Athena, will be invaluable to the Company as we navigate our opportunities for growth and expansion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
GHG's Chief Marketing Officer, we also welcome the deep knowledge and experience in sales and customer base marketing that Bryan
brings to our Board. This will be important as we focus on ramping up our sales and marketing effort.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
we continue to build momentum, we expect the market to also take notice, so we believe our ability to capture more channel is
essential to keeping our leadership position. For this purpose, we plan to deploy some of the new influxes in capital to acquire
additional access to HCPs. Also, simply having a stronger balance sheet enhances our position as we work to secure new clients
and channel partners and it provides some additional flexibility as we consider potential strategic options. This strategy is
in line with the comments we've made in past calls and investor presentations, that if we were to raise capital, it would be for
the purpose of securing additional channels and reach for our clients. The major announcements of our network expansion during
the quarter have also raised our profile in the industry, which has led us to now being actively engaged in discussions with several
additional EHRs for integrating our technology into their platform.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are working extensively with our existing platforms to expand the reach of our financial messaging in&mdash;to additional HCPs,
as well as increasing the utilization by existing users. Driven by the launch of additional channels, more brands, more solutions,
as well as the ongoing growth of our national EHR network, we expect to see continued revenue growth in 2018 and beyond. While
we are focused on the top line, we are also carefully managing our expenses. Together, we believe this will keep us on track to
achieve profitability on a quarterly basis, by the end of the year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Now
with that, I'd like to open the call to questions. The fun part. Operator?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Operator:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thank
you. If you would like to ask a question, please signal by pressing star, one on your touchtone telephone. If you're using a speakerphone,
please make sure your mute function is turned off to allow your signal to reach our equipment. Again, press star, one to ask a
question. We will pause for just a moment to allow everyone an opportunity to signal for a question.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We'll
go first to Eric Martinuzzi with Lake Street Capital Markets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">1-888-562-0262 &nbsp;&nbsp;&nbsp;1-604-929-1352&nbsp;&nbsp;&nbsp;&nbsp; <U>www.viavid.com</U>&nbsp;</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><IMG SRC="eximg_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Eric
Martinuzzi:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Just
a terrific quarter, really, just stunning to see this kind of growth. I think I said it last quarter when you did over 70% growth
but this quarter at over 91%, I just don't have a lot of names in the coverage universe like this one. I've got a bunch of questions.
I'm going to try and put them in four different buckets and be quick about it but I want to focus on, obviously, the quarter you
just reported, your outlook for the year, the private placement and then the NASDAQ uplisting. On the quarter, one thing I noticed,
and maybe this is a Doug question, maybe it's a Will question, but this related-party revenue, I understand, just taking a quick
look at the Q, that seems to be tied to your WPP director and that related party, does this&mdash;is there a revenue concentration
here? Or is it just kind of that WPP relationship equals a bunch of different customers?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes,
that's&mdash;good to hear your voice and thanks for calling in, and yes, we're thrilled with the progress on this growth. To answer
your specific question, that is not an over concentration. We have a really nice spread of revenue. I think we've talked in the
past that revenue coming from that relationship can be anywhere from 15% to 20% but it's lots of relationships, it's not just
one. There are several agencies under the umbrella of WPP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Eric
Martinuzzi:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Okay.
All right. Then, this one is probably for Miriam, just EvidenceCare, you're sort of opening up a new growth vector here. I did
see, just going through the press release though, it's only 5,000 users. You guys have over 500,000 users elsewhere in your EHR
channel, what&mdash;explain to me, I guess, the opportunity with those 5,000 versus your existing install base of HCPs?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Miriam
Paramore:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes,
thanks, happy to. There really are a couple of things that are strategic about this, more than they are expansive in terms of
share numbers but the strategy far outweighs just their 5,000 touch points today. They are an early-stage Company and that's why
their user count is pretty low at this point but they are in some key hospital systems and that's a place that we've been striving
to get to but have not yet had an actual firm footprint. For example, EvidenceCare has a relationship with MedStar, which is a
15-hospital system, with 10 additional urgent care centers. MedStar is a Cerner innovation site.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">First
of all, it puts us in the flow of the hospital setting. Secondly, it gives us that direct integration to Cerner through EvidenceCare.
Then, thirdly, it opens up, as you said, a new vector of channels, because there are many, many, many clinical decision support
vendors out there that are essentially overlays to the electronic health record ecosystem and so we want to be embedded in all
of those things. Once we are in there, we have these jumping off points to the major EHRs who are the incumbents in the hospital
system (inaudible) systems, rather, it helps to accelerate our growth in the hospital setting. That's really why we're so excited
about it.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Eric
Martinuzzi:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Okay.
Thanks. On the 2018 outlook, Will, I know you've talked in the past about you'd be disappointed with less than 30% growth. Given
the 91% growth in Q1, that forecast looks laughable, in my opinion. Would you care to revise the 2018 growth target?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">1-888-562-0262 &nbsp;&nbsp;&nbsp;1-604-929-1352&nbsp;&nbsp;&nbsp;&nbsp; <U>www.viavid.com</U>&nbsp;</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="eximg_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">How's
31%? No, I'm just kidding. I think we don't give guidance and I'd like to under promise and over deliver every day. But yes, I
mean, it's&mdash;we really&mdash;in this particular growth to this quarter, my hats&rsquo; off to the ops team because they really
got things to move faster than it's traditionally been how it works in this business. I'm not going to promise 91% growth, would
never do that, but I guess I would up it to, I'd be disappointed with 40% growth for the year and each quarter we can look at
that a little bit more. Feels like we're growing up towards the guidance, eventually but&mdash;and that's&mdash;I'm comfortable
saying that.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Eric
Martinuzzi:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Okay.
That's fair. Rather than go through the entirety of the rest of my list, I'll take these off-line but I do have one question on
the private placement, congrats for getting that $9 million raise done. You don't&mdash;I looked in the use of proceeds; it looks
to be, general corporate purposes working capital, what about M&amp;A? Is this private placement? Is it a potentially used near-term
M&amp;A opportunity?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
we've talked about, we've got these three levers in the business, right? More brands, more solutions and more reach. The quickest
to increase revenue is getting more reach because we already have a lot of brands and we have two wonderful solutions but we are
always looking at solutions for the middle, and if we were to do something in an acquisition, it would probably be there. There
is nothing on the immediate horizon, but I think given the steps we're taking with the balance sheet, getting on exchange, those
things become more realistic, but really, just focused on executing and growing off of a good organic business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Eric
Martinuzzi:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Got
you. Congrats, again. Terrific quarter. That's it for me.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thanks,
Eric.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Douglas
Baker:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thank
you.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Operator:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a reminder, everyone, that is star, one to ask a question.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Next
from B. Riley FBR, we'll hear from Andrew D'Silva.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Andrew
D'Silva:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hey,
good afternoon. Thank you very much for taking my questions. Just a couple add-ons. I'll just start with your EHR partners that
you're working with currently. Can you maybe give an update as far as how many of them are migrated over to a cloud-based platform
from a server-based platform? I remember a little while ago that was a headwind that you were facing and it seems to be working
its way out of this plan, at least by looking at the numbers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">1-888-562-0262 &nbsp;&nbsp;&nbsp;1-604-929-1352&nbsp;&nbsp;&nbsp;&nbsp; <U>www.viavid.com</U>&nbsp;</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="eximg_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes,
we don't disclose the actual, because we treat our EHRs almost like clients in terms of what we say and talk about, but of the
ones that have been added in the last six months, a high percentage are cloud-based. Some are the ones that we're going after
are as well. But it's still&mdash;the biggest ones are still predominantly server-based. Another reason why this capital was important
is to try to facilitate some of that better utilization of the server-based partners and then go after the remaining cloud-based
group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Andrew
D'Silva:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Okay,
I see what's going on. That makes sense. Is there just a macro theme that EHR platforms will gradually move over to cloud-based
over time? Or are some of them just so rooted in server-based that you don't see that actually ever happening?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miriam,
do you want to talk to that one?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Miriam
Paramore:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
Sure. It's a good question. The majority of the early&mdash;earlier or newer EHR systems are tending to be native in the cloud
and tend to be specialty focused. Those guys will have a smaller footprint by the numbers in terms of their number of providers
that they turn on much faster. In terms of the general market, I think the acquisition spree that you've seen if you kind of go
back and look, anyone who has purchased an EHR, that was already an existing EHR, tended to go by a cloud, a native cloud-based
solution. You&rsquo;ll see them migrate their book of business or run the tail down off of their traditional server-based platforms
to their cloud-based platforms. But that takes a long, long time. Migration from any one platform to another is always a very,
very long and painful process in health care, as I'm sure you know if you&rsquo;ve followed this sector for a while.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">But
I'd say a good indicator of what we're seeing is that on our pipeline for folks who are not already on our network are that more
than 50% of them, probably more than 70% of them, are native cloud-based. The newer, the more cloud but the smaller their footprint,
is the way to think about it. Their speed to ramp up is very quick. Then I would say your bet is correct, that older EHRs are
either having a secondary platform that's cloud-based or migrating or some are building from scratch. But that has a transaction
cost and time to it. I hope that helps.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Andrew
D'Silva:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Okay.
Good. Yes, that's great color. Thank you very much for that. Then, just moving over, kind of to the different offerings. Obviously,
financial messaging has been the backbone of the Company for quite some time. How do you see the business developing as we go
into '18 or finish out '18 and '19? Do you think that all offerings will continue to grow but things like clinical brand messaging
will start to take a bigger percent of the overall top line pie?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">1-888-562-0262 &nbsp;&nbsp;&nbsp;1-604-929-1352&nbsp;&nbsp;&nbsp;&nbsp; <U>www.viavid.com</U>&nbsp;</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><IMG SRC="eximg_002.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No,
I see growth in all areas. As a matter of fact, we had a national sales meeting and I put some math to the brands remaining that
we don't have. We have a lot of room for growth just in that one offering. Then, our other messaging solutions, as you know, really
just started last year so they will continue to grow quite a bit. We don't break out revenue, it's&mdash;we're still too small
for that and it's also really becoming the digital health messaging platform. I think we're going to see continued growth across
the board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Andrew
D'Silva:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Okay.
Great. Just a last question. When we think about the different brands that you're working with, obviously you gave some color
on how not all brands are equal. Could you give a sense of any potential concentration risk that might be taking place of any
brands or any brands that are significant to you that might be rolling off patent doing that or is that not necessarily a concern
that you have at this time, based on the brands that you are working with currently?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
We, starting about 1.5 years ago, we really did a good job of going and looking at when brands are on patent. We obviously can't
predict any FDA action or merger and acquisition at the pharma level action. But we do not see a high churn year this year and
'19 as well. Particularly, because there's a lot of new brands coming on to the market, we're in good shape to bring those on.
I feel good about not too much customer concentration and then a layer down, not too much brand concentration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Andrew
D'Silva:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Okay.
Wonderful. Hey, thank you very much. Congrats on the progress and good luck going forward.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thanks,
Andy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Operator:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Next
we'll hear from Harvey Poppel with Poptech, LP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Harvey
Poppel:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Well,
not only congratulations on a great quarter but you answered my perpetual question about uplisting which is very gratifying to,
not only me, but I'm sure a lot of other major investors in the Company. Couple of questions about the private placement. If I
do the math correctly, your announcement had mentioned three parties, two institutional investors and a family office. If you
divide the five million shares by three, it suggests that each of the new owners will be right around that 5% reporting threshold.
Will, can you disclose whether their names or whether any of them will be over the 5% in order to meet the reporting requirements
so we'll get to know who they are?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes,
Harvey, we&mdash;not comfortable talking to the investors. I like them to talk for themselves but you will see through filings
who everybody is.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">1-888-562-0262 &nbsp;&nbsp;&nbsp;1-604-929-1352&nbsp;&nbsp;&nbsp;&nbsp; <U>www.viavid.com</U>&nbsp;</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><IMG SRC="eximg_002.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Harvey
Poppel:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Okay,
fine. With the new private placement and uplisting, do you think there's a good chance for the Company to achieve a greater, wider
analyst coverage at this point?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
do. I think I spent a lot of time, as you know, because you're at these conferences, really talking to a broad base of investors.
Not just those, that&mdash;not just the family office group that are usually early, early believers. But also the institutions
who frankly couldn't buy our equity, given our share price and/or the OTC listing. I believe we've got a much broader story; those
stories are then shared with analysts and I think we do have a chance of having additional pickup, based on this transaction but
also just based on the story. I mean, health IT has been a lot of promise and a little deliver and I think we're doing a lot of
delivering right now. It's a good story. I think, it's easy to understand, right? We digitize communications for pharma, we're
addressing a price, expensive prescriptions, we're helping physicians and patients and outcomes. It's a good story. I think it's
easy to tell.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Harvey
Poppel:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
had just one further question that relates to EvidenceCare. I think, in Mary's remarks, she mentioned Cerner's name with&mdash;in
relationship to that, if I heard correctly. Could she elaborate further on that what's the&mdash;what that connection is?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Miriam
Paramore:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sure.
Happy to. Hi, Harvey. EvidenceCare is a clinical decision support piece of software that's actually separate from the electronic
health record. I used the word overlay because there is a class of software, and lots of it, that is not part of the EHR when
it comes out of the box but kind of overlays it and enhances the functionality. This clinical decision support software, which
is tablet-based and used at the bedside, lots of times in the emergency room setting where you have a generalist who is delivering
care and patients with any number of things coming in the door. It helps them to quickly go through evidence-based guidelines,
coupled with the hospital system's own guidelines and then makes treatment recommendations including prescribing recommendations.
Right there, in their hand, in a mobile settings, we're able to share clinical decision support or medication management information
with those healthcare providers when they are making treatment decisions. Behind that, in many cases, there is a Cerner installation
and so I mentioned MedStar as an example that is a Cerner innovation site, 15-hospital system.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">What
happens is, through our connection, if it were a financial message, as an example, through our connection, that the provider chooses
a medication and a patient savings opportunity is available and they hit go, or submit; that flows back through the Cerner system
to finish the cycle of electronic prescribing or ordering. It allows us to have that seamless integration and from there, we can&mdash;we
believe we can optimize other points of workflow with Cerner, even when it may be in a different care setting. Hope that helps,
Harvey. It's kind of a plug-in that allows us to connect to Cerner or one step on it because EvidenceCare has already done all
that work. We get the benefits of that kind of bidirectional information exchange,which is critical to our scale.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Harvey
Poppel:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wonderful.
Thank you very much. Appreciate it. I&rsquo;m done.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thank
you.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">1-888-562-0262 &nbsp;&nbsp;&nbsp;1-604-929-1352&nbsp;&nbsp;&nbsp;&nbsp; <U>www.viavid.com</U>&nbsp;</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="eximg_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Miriam
Paramore:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
are welcome. Thanks, Harvey.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Operator:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
again, everyone, that is star, one to ask a question.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Next
we'll hear from Ron Chez, and he is a private investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ron
Chez:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Good
afternoon.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Good
evening.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ron
Chez:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That's
right. Good evening. Just one question, maybe two. Are you seeing evidence of greater dollars? Somebody asked about concentration
and that, you said, is not a problem, but are you seeing bigger dollars from individual brands?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes,
Ron. Good question, good to hear you voice. Last year, I think, we talked about having two million-plus clients; that doesn't
mean brands but the manufacturers. This year we have over six of those and two&mdash;and then we have two that are over $2 million.
We're starting to see this ROI data really help clients get more comfortable with increasing their spend, not only on current
brands but bringing other brands into the mix.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ron
Chez:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Okay.
You're not going to get too comfortable as a result of having a good quarter, right?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Never,
never. The good thing about our clients is they keep us moving and obviously the team is incredibly charged up and that kind of
culture just pushes you to do more. We're very excited to keep it going.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ron
Chez:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">They
have open-ended incentive plans?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes,
everybody does.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">1-888-562-0262 &nbsp;&nbsp;&nbsp;1-604-929-1352&nbsp;&nbsp;&nbsp;&nbsp; <U>www.viavid.com</U>&nbsp;</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="eximg_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ron
Chez:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Just
one more question about the brand messaging and you talked about high fixed cost. Do you want to comment on that? The nature of
the high fixed cost and why that's going to get better traction?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
We talked about it last year where we were actually pre-purchasing inventory, which is&mdash;then we sell again and last year
was our first year doing that. We saw, as we said, each quarter, our margin would get better and better. We got very good at doing
that. We also negotiated a better deal within 2018. You couple the two together and we've got really nice margin improvement.
As the year progresses, that fixed cost actually goes down because it's sort of top heavy in the first half. We expect some good
improvement there and continue to sell really well against it.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ron
Chez:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further
penetration with more brand messaging, people are responding to that, the agencies?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Douglas
Baker:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
Well, you know this whole point of care space is really hard to get a clinical-oriented message to, right? The reps can't get
there, doctors are on computers, everyone's overworked and so it's really up to us to deliver a simple effective message at point
of care. We have the beginnings of a very powerful network to do that. Yes, more penetration and definitely clinical in nature.
We're looking at outcomes not just pretty pictures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ron
Chez:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thank
you. Anything else I have, I will do offline. Thanks. Good job.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thanks,
Ron. Appreciate it.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Operator:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
this time, this concludes our question-and-answer session. I would now like to turn the call back over to Mr. Febbo. Sir, please
proceed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">1-888-562-0262 &nbsp;&nbsp;&nbsp;1-604-929-1352&nbsp;&nbsp;&nbsp;&nbsp; <U>www.viavid.com</U>&nbsp;</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><IMG SRC="eximg_002.jpg" ALT=""><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>William
Febbo:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Well,
thanks, everyone, for calling in. We will not get too comfortable, we will continue to manage expenses and we will try to accelerate
growth. I do want to say that the team is really cranking. They are working hard and delighting the client. That is what you need
to do every day. We'll continue to work for the investors as well, as we do. I look forward to talking at the next investor conference,
which I believe is B. Riley in May. Looking forward to that. Everyone, have a great rest of their week.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Operator:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thank
you. Now, before we conclude today's call, I would like to provide the Company's safe harbor statement that includes important
cautions regarding forward-looking statements made during today's call.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements
made by Management during today's call may contain forward-looking statements within the definition of section 27A in the Securities
Act of 1933, as amended, and the section 21E of Securities Act of 1934, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
forward-looking statements should not be used to make an investment decision. The words anticipate, estimate, expect, possible
and seeking and similar expressions identify forward-looking statements, and they speak only to date the statement was made. Examples
of such forward-looking statements in this presentation include statements regarding achieving GAAP profitability on quarterly
basis by the end of the year, positive cash flow from operations and future quarters in 2018, plan to deploy capital to acquire
additional access to HCPs, plan to implement a one-for-three reverse stock split of its common stock, distribution of financial
messages, would continue to increase, brand messaging will continue to support top line growth, margins will increase, ROI data
will help encourage the adoption of the Company's cloud-based EHR channels by potential clients, further improvements in cost
of sales percentage in future quarters, rollout of its integrated messaging service with new channel partners, operating cost
levels to remain at similar levels or only increase slightly for the balance of 2018, continued growth in 2018 and the Company's
estimation of the total available market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company undertakes no obligation to publicly update or revise any forward-looking statements whether because of new information,
future events or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot
be predicted or quantified.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
events and actual results could differ materially from those set forth in, or contemplated by underlying forward-looking statements.
Risks and uncertainties to which forward-looking statements are subject and could affect business and financial results are included
in the Company's annual report on Form 10-K for the fiscal year ended December 31, 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
form is available on the Company's website and on the SEC website at sec.gov.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
we end today's conference, I would like to remind everyone that this call will be available for replay, starting later this evening
through May 23. Please refer to today's press release for dial-in replay instructions available via the Company's website at www.optimizerx.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thank
you for joining us today. This concludes today's conference call. You may now disconnect.</FONT></P>



<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-right: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-right: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 100%; text-align: right">13</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ViaVid has made considerable efforts to
provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of
the conference call. This transcript is being made available for information purposes only.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1-888-562-0262 &nbsp;&nbsp;&nbsp;1-604-929-1352&nbsp;&nbsp;&nbsp;&nbsp;
<U>www.viavid.com</U></P>

</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-right: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-right: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-right: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>eximg_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 eximg_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" '[ L4# 2(  A$! Q$!_\0
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MT31C_P PG31]+"U_^-4_[&E_T$17_<*7_P F'^M=/_H!J/\ [CT__E9\*_\
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M"R.3_P"8F*?5.E*__I?XDOC&FO\ F7U&NC6(IV_]-?@?&7_">>//^AZ\;?\
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M ,;JUPY-ZK&0_P#!,_\ Y,F7'=)?\RRL_/ZU2_\ E)\R_P#">>//^AZ\;?\
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MT_BG_P!U'#?_ #*;?_">>//^AZ\;?^%=XB_^65'_  GGCS_H>O&W_A7>(O\
MY95@-&.H ^F/Y?X?_JJ/:/0?D*I<"5FKK,Z+\OJM6_\ Z>(_XC1A?^B>Q/\
MX<</_P#,IT?_  GGCS_H>O&W_A7>(O\ Y94?\)YX\_Z'KQM_X5WB+_Y95SF!
MZ#\A1@>@_(4O]1:U[/,J2_[E:O\ \M#_ (C1A?\ HGL2_P#NHX;_ .93H_\
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M:<Q5N_\ :6&_^9#]_J*_*K]G37]=O?\ A,?MFMZO=^5_PCWE_:M2O+CR]_\
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M_P"JH_K33:U1E*'S7XK^NYF/&1G'Y?U'^?\ "H&4'V/^>HK6:,'H/P_P]/\
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MV(:3T94(!ZU$RD>X_P ]:M,G<?E_A4?UJDT]ONZHRE%K;5?EZE)XP>@_#O\
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M?^W2+K7YR:[_ ,AS6O\ L+ZG_P"EL]?HOH?_ "!='_[!>G_^DD-?%95\5?\
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MY]ZTC/H_O_S,)0ZK[O\ +_(S&0CD<C]14+(#R.#Z=O\ ZU7F0CI^7?\ ^O\
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M7_'TJ<@C@TE4I->:[&4HM:K5?EZGTI^SE_S.7_<O?^YRBG_LZ #_ (3''?\
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MB:>J"BBB@8A4'Z^M1%2/IV-344$RBGY/O_F5Z*D9.X_+_"HZ"$Y0=GM_6PA
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M=>/O^HZ_C_G\JKD$=:N,FM]5^7H82A\G^?\ 7<HLA'N/U'U_QJ%D[CCV]?\
M#^5:14'Z]C59XR.GZ=#_ ('_ #[UJFGJC&4>C7]>3*#*#U&#^HJ%E(X(X_2K
MS+G((P?7N/\ ZU0LN.#R#_G\*I-K5&,HM>:[_P"919".1R/3O_\ 7J%D!],^
M_0U>9,<CGV[C_&H60'D<'^=:QDGY/^MC.45+U_K<SFC(Z#\/\/7_ #UJ.M!E
MSP1_GV_SBJ[Q]_U[?C_C_P#JJCFG3:V^[H_0ILG<?E_A4=62".#3&4'Z^O\
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MD \&H7C[_KW_ !_Q_P#U5:UU6DNW1^G;T>AC*'5?=_6Q29.X_+_"H64'V/\
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MK(5S[?F/_K?Y]Z81G@U?90>".?UJN\??WZ]C_@?_ *_UJTVM4S&4.^J[]O\
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M Y'?']M=??G_ .O17Q.<6_M'$6V_=?\ IFF?L/"BMD.!3_ZB?_4NN?*>N_\
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M494@LM(T#P_83ZGJE]/(Y4;8+2WD94!WROMBC#2.JGN64-]?6OXN_P#@ZO\
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MY^QZA;3026>I:9=%2\<.H6$W[V SQ#SK:4%X+F++P2R!6V_E%_P4M^!/Q/\
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M^!_P_&M(SZ/[_P#,YY0[?=_E_D9C(1R.1Z=__KU"R \C@_SJ^R$9Q^7<?XU
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MFVVWW;;;*]%3,H/L?6HB".M,RM*#TV_#YG^<9_P=_P#_ "D$^!G_ &;#H/\
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M:V\3%?B)I6,QPHI(W,''3[K*KCHRA@5'Q+^WG_P;P_LT_M^_M)^+/VF?B/\
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M>,'H,_S'T_P_G5-X^_ZCI^/^?SK2((X-,90WU_0_6JC)KS7;_(PG#OH^_?\
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M2_X#_P A]*"1TI** <&M8_\ !7]?U<F5@?8^G^'K3JKUE>(8=2O?#VNV6D7
MM-7N]&U2VTJ[)VBVU*>QGBL;@M@X$-T\4A;!QMS@T#C.[2D[:I7>V]KOM;=^
MA\U^+_VXOV6_ OC>;X?^)/BSHEIXALKY=,UEX+;4[_1?#NHO((4LO$?B&QLK
MC1=%N&E/EF._O82D@>.0H\<BKTWQE_:P^ GP$.D0_$GQ]8Z=J>OVL=_HNA:3
M::AXDU_4].DW;=2M-'T"UU"]?3BJ.ZWAB6!T21XW=(Y"OY4_ +X\_L[? _\
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MJ/QC_:,9TET>;[,D*2#]ZUZUUFU&GK$;X7(,!MQ*"@^/#^W#X:^(?Q]_9_\
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MJ?W&4H=M5V_K<I,@/U_0_6JK1D=!^'^'K_GZ5>92OT_SU%,(!&#6L9]']_\
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M-3*Q'N/Y?2J@(/(IZL1]/3_"OJC\WC)/1Z/\_0O*W<'_ #[BK"2= ?R_J/\
M#Z_6L]6[@_Y]Q4RL#['^?TH:3T9JI->G8TE;N#_GW%3*P/L?Y_2LU9".OY_X
M^O\ GK5E7!]C^AK*4&M5JOQ1JFGL7 2.E2*X/!X/\ZJJ_8\^_I_C_.I:S:OY
M/HU_6II&=M'JN_7_ ();5\<'GW[C_&I0<\BJ2N1P>1Z]_P#Z]3*Q'(/'Z5+U
MTEH^DEM_7D_O-4[[%I7*X]OS'_UO\^U65<'K^?8_X52# _7N*<"1TJ6FM):K
MHUNOZ[/Y%QFUH]5^*+]2J_8_G_C_ )Q5-).WZ'K^'J/;^53 @\BHE'K]TE_6
MGHS52[:I].C+-2*_8_G_ (U55B..H_STJ4$'I_GZU#[2^4E^O;\C12[:KMU7
MIW7EN6U8CW'^>G^<5,K=P?\ /N*HAB/<>E3*W<'_ #[U+3CYK\'ZK^O)FJDF
MNZZ=UZ?Y,O*P/L?Y_2G555@>O!_G]/\ "I5?L>??T_Q_G2LG\._;_+O^9HI=
M]5W_ ,UT?X$X8K]/2I00>E04 XY%266* <<BF*X/!X/KV_\ K4^@I2:TW7;^
MO^&)5?/!X]_7_"GU7IZL1UY'\OI_A6<H=8_=_D6N\=5UCV].WIMV):*0$'D4
MM"G;27W_ .92:?\ 6J]217['\_\ &I*KTX,1[CTH<$]8_=T^0R:BD!!Z?Y^M
M+68"@D<BI58'KP?Y_3_"H:*!J37IV+%%1*^.#S[]Q_C4H.>10:>[->?XK_-?
MUH ..14JN#P>#Z]O_K5%103[T'Y?@_\ )_UJ6**B5R.#R/Y5*"#TH+4D_7L%
M%%%!05&R=Q^7^'^'_P"JI**!-)[E>BIBH/L?7_'UJ(@CK09M2@[K;\/F)3&3
MN/R_P_SBGT4%)QFK/?\ K9E>BIRH/U]:B*D?3L:")1:\UW_S&T444$D3)W'/
MMZ?X_P Z95BFLH/L?Y_6M(SZ/[_\P(:*4@C@TE#A?6/W?Y":3W(V3N/R_P /
M\/\ ]51U8IK*#['U_P ?6A3:TE]_5>HGIH]8]^J]>_JM2&FE0?8^O^/K3R".
MM)6FYFXVU6J_K^OS("".M)5@C/!J)DQR.1^M!)"R9Y''MZ_X5"RYR",'U[C_
M .M5FD*@]?S[U5[Z2^3ZK_->1+CVZ[I[/_)^:*++C@\@_P"?PJ%DQR.?;N/\
M:O,I'49'\ZB9.X_+_#_.:-8ZK5/[G_DS-QO>R]8O=?YKS13J-D[C\O\ #_.:
MM,H/3@_S^O\ C41!'!JTT]8Z/JGL_P"NZ^9DX_-?BO3NO)_(K5$\8/0?AW_#
M_/\ A5ME!YZ'_/6HB".M7&739]8OK_GZHS<?FN_^?9^I092OT_SUIA /!J^R
M@^Q]:K/&1T_^M^'^!]>U6N\=^L7^G?\ -&4H=5]W^1492/<?R^M0LG<?E_A5
MRF,G<<>WK_A_*J33U6DNJZ/_ #_,S*5,9.XX]O7_  _E5IE!ZC!_45"5(^GK
M5)]'H^W?T?4SE#JON_R*K*#U&#^HJL\>.G_UC_@?\^]:)4'K^?>H64CJ,C^=
M7&37FNW^1DTGHU_P#-90>".?UJ%E(ZC(_G6B\>>G/\Q]/7_]76J[*1[C_/6M
M4T]C*46O-?UN463N/R_P_P YJ.KC)W'Y?X5"R@\]#_GK3,Y13\GW_P RH\8/
M0?AW_#_/^%5'B[_K_B/T_P XK1((.#3&4-]?\]151DUZ=C"<.^CZ/^M_S,EE
M[$?Y]1_GZU"RD<]1_GK6F\7MWZ=OP/\ G^E560CW'ZCZ_P"-:II[&,HVT:T/
M8/@X /\ A(\=_P"R/_<I14GP@ '_  D6._\ 9/\ [DZ*^8S*4OKE;7_GWV_Y
M]0/T7((1_LG"Z?\ /_K_ -1%4^!==_Y#FM?]A?4__2V>OHK3F*V-EZ?9+;ZC
M]RG2OG77?^0YK7_87U/_ -+9Z^@[!B+*S[C[+;\?]L4K'AC^)C/\%#_TNH=7
MB([4<I7>MB[?^":)N1R].?Q_H1_7_P#75I6#?7]#]*R5;N#_ )]Q4Z2=OT/3
M\/0^W\Z^KE"^JW[?UL?F49VT>W?^MS2!(Y%2JP/7@_S^G^%5$D!ZG/\ ,?7_
M !_G4M9;'1&??5=_ZW+:OV//OZ?X_P ZF5B.AR/YU15\<'GW[C_&IE;'(.1Z
M>O\ ]>@U3ZI_-&BDF>O_ -<?XC_/M4ZL1R#Q^E9JL#T.#^HJ=),=?_K'Z^G_
M .NHE!/5:/\ !_Y&L9WT>C[]'_D:(8'Z]Q3@2.E558'IP1_GBI5?L?S_ ,:R
M:Z-?)FBDUM]Q:5@?8_YZ5,K]C^?^-4ZD5^Q_/_'_ !__ %U-FO./;JO3NO+?
ML:J2?KV+E2I(01G\_P"A_P _XU45B/<?YZ?YQ4H(/3_/UJ;6UCJNJ_3^M46F
MUL7U8-]?T/TIX)'(J@K$>X]/\/2K*2 ]3G^8^O\ C_.ILGM\XO\ 3OZ;FL9)
M^3_K8MJP/7@_S^G^%/!(Z56IZOC@\^_<?XUG9K;5=8OIZ7_)_(U4OD^_1^J_
M4M*X/!X/\ZF5\<'GW[C_ !JH#GD4]7QP>1^M2XWUC]W5?UV_$TC*S[/MT:\N
MZ_$O*V.0<CT]?_KU,&!^O<515B.0>/TJ96STX(J;IZ2T??\ S7Z[FL9=O_ ?
M_D7^C+-/5R.#R/Y5"K]C^?\ C_G%/I--;_\  ?H6FGM_P5ZE@$'I14 )'3_/
MUJ56!^OI_A2*3:U0\$CI_GZU*K _7T_PJ&BI<4_7N6FI?W9=^_\ GZ/[RQ14
M:OV/Y_XU)4>]!^7X,I/H]'T?1^G^0H)'2I%<'@\'^=1457NS7G^*_P _ZV*+
M%%1*Y'!Y'KW_ /KU*#GD5FXM;_> 4H8CI^7:DHI!ML3!@WU]*=5>I%?L?S_Q
MH-%-/27_  '_ %_5B2E!(Z?Y^M)10#@UK'_@_+O_ %N3*P/U]/\ "G57J17[
M'\_\: C/H_O_ ,R2BBB@T"@C/!HHH B9,<CD?K3*L4QD!Y'!_G09RAUC]W^1
M%12D$=:2@%/I+[_\R-D[C\O\/\YJ.K%-90>>A_SUH"4+ZQ^[I\B&BE((.#24
M&8A (P:B92.>H_SUJ:BJ4FO3L!7HJ5D[C\O\/\XJ*K]V:\_Q7^8 0#UJ)D(Y
M'(_45+14^]!^7X/_ "?]:DVMK'YKH_\ )_TRO14K)GD<']*B(QP:T4D]ON)<
M5+;1]5_7YK08R \C@_SJ,@CK4](0#UIF;36C(*C9.X_+_"IF4CW'K_CZ4VFF
MU^JZ,32?Z/JBJR@\]#_GK4++U!_S[BKS*#]?7_&H67L1_GV-.U]8[]NOR[_F
M0X]]'_-T?KV?GL464CGJ/\]:80#P:MLI'N/Y?6HF3N/R_P /\XJE)/26_1[?
M\-_6AE*+3[/\'Z]_5%5E(Z<C^7U_QIA /6K%,9,\CCV]?\*J[6^W22_6VWKL
M9./;1_R_Y/K^93>/O[=>X_Q'_P!?ZU7*D=?S[5?(QP:8R!L^_P"1_P#K_P"?
M>M+I[Z/I)?K_ )HSE%/R?];E$J#]?6H64CJ,C^=6V0C./R[C_&HZJ_2?R?ZW
M_5?-&336C*3)W'/MZ?X_SIE7&3N/R_P_SFH64'V/\_K57:WU7=?K_FOF1**?
MD^_^959.X_+_  J%D!^OZ'ZU;((X-,90?KZ_XU:=M4S)IK?_ (!G-&1T_+_
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M[VUEA:OM/9T;8I\D:BEAN:K%PDKJ32CS0:VE&I&$HO1J[5_U@HKX[^*W[?\
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M4CW'K_CZ4VK%1LG<?E_A_A_^JG&?1Z>?^?8E]I?*2_7M^1'4;)W'Y?X?X?\
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M2Z=]H\26EM/X9\.7,=MK#WD(N]!T>[*&YTVSEA[+QI^QI^R7\1OA!X,_9_\
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MQ_GI4RMGD'_/O_G%9M6U6J[_ .?8TC/H_O\ \R^DG;U[=C]/0_YYJVDF>O\
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ME%4FI*SW_K8HL YY%%0 D=*E# ^Q]/\ #UJ)1:\U_6X#J***D"17['\_\?\
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M4Q->-"$%5J>RA[TH33<I^[:R>JUU/ZU%?'!Y'ZU*#GD5^'.O?M%_\%@?A/\
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M@C\;+KPNZQ^)K;X1_%;P)\2)_#LC3/;JFNP^#=>UF32':XBD@5=06W8S1O$
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M>PU3Q'X?T2+6M)\,ZAJ$5R^AV_BG7Y].%O?7,=U%\C_L;_ [X7Z__P $B?\
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MV0Y]4U74;J7[1<ZAJ6H?#'XGW=]>W,Y+>=/=W4TL\TI)\R21GR=V:_2C2_\
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M_P#!$92?^"NG_!PCCM^TCX"X[_\ )0?VD:_J6KY+^ 7[#/[.'[,WQI_:5_:
M^$'A'5= ^*'[6_BG3O&7QQUJ^\6>)=>L_$NOZ5J?BG5[*ZT[1M8U*\TKPY%'
M?>,M?D:UT*UL;>1;J*-XVCM;=8_KIE!]CZUV48.G3Y96OSU9::JTZLYKHM;2
M5_.YY>-J1Q%;VM.Z7L</"TDDVZ6'I4I6LWHY0=M=59NST4-%*01UI*U.$0@'
M@U&RD=.1_+Z_XU+15*37IV KT5*R9Y''MZ_X5$1C@U?NS7G^*_S7]: !&>#4
M3(1R.1Z=_P#Z]2T5/O0?E^#_ ,G_ %J3:VL=/+H_\GYE>BI60'D<'^=1D$=:
MT4D_7L2XJ6VDNJ?]?BOF,90>G!_G]?\ &HB".#4](0#UIF;36C(*C9.X_+_#
M_#_]53,I'T]?\:;33:_5=&)I/]'U1590?8_YZBH67L1_GV-7F4'V/K_CZU$R
MXX(_S[?YS3M?6.C[=?EW_,AQ[Z?WNC]5T?F464CIR/Y?7_&F$ ]:MLA'(Y'\
MJA9,\CCV]?\ "J4D])?)[-?Y?U<RE&S[/\'Z]'ZE5D(Y'(_44PC/!JP1C@TQ
MDSR.#^E5=K?5=)+]?\UH9N/;1]O_ )%]?3<]#^'<?.LXQ_S#^O\ V_45)\.Q
MC^V0?^H?_P"WU%>'C7?$U'_@_P#2(GV>4?\ (OP__<7_ -/5#\P-=_Y#FM?]
MA?4__2V>NK@?]U$#_P \TY_X".O^<_6N4UW_ )#FM?\ 87U/_P!+9ZZ6W.88
MO41QY_[X%>MP4DZN8I_\^L-_Z<JGS/BW+EPV1>>(Q_\ Z8PQ>J17(Z_GW'^-
M50Q'T[BI0P/U]*^ZE%KS7?\ S/Q>,NJ?]>:+RN"!G\^Q_P #_GVJ97QP>1^M
M9H8CI^7:K"2=NOMW'^/_ .KI4G1"IT_#_+_(T%;'([_K4RL#TX(_SQ5%6QR#
M_GW_ ,YJ56!]C_GI6<H=5]W^1NFGJB\K]C^?^-3JY'T_4?2J"OV/Y_XU,K$>
MX_ST_P XK,UC/H_O_P S260'K^?^(_S_ %J3Z5GJW<'_ #Z'_/TJPDG;].WX
M?X?_ *ZEQ3]>YK&36VJ+BR$=3^/^/K_GZU:5P?K^A^E4 0>E/#%?IZ5DTUN;
MPGV^:?\ 7XFDK]C^?^/^<U*K8Z<@U023/7_ZX^OK_P#KJ=6(Z'(_G4./;YI[
M/_)^ANI)[?<7E;/([?F*F5\\'@_I5%6SR#@^G<?_ %JF5\\'CW]?\*S<=[=-
MT]U_FO-&D9VT>J_'_@EY7*X]OS'_ -;_ #[5;27W_P #_@?\^U9BN1P>1^HJ
M96QR#_GW_P YJ'%/?[S:,K:IW7X&L&!^O<4X$CI6>DO_ .K/(^G^?RJVL@/4
M_C_CZ?Y^M9.+7IW-X3[?-/\ K\46E8'V/^>E3*_8_G_C5/Z5(K]C^?\ C_C_
M /KJ3923]>Q>5R,>G^>15E) 1S^??\1_7_\ 76<K$>X_ST-3*W<'_/N*32>Y
MI&36CU7Y>AI*Q'N/3_"I00>E9Z2=OT/3\/0^W\ZLJV>0?\^_^<5E*+7FN_\
MF:IWU3+08K]/2I5;/(./\]ZJJX/!X/\ .G@XY%0UU6C_  ?JOZ9K&?1_?_F7
M5?/!X/Z4\''(JHK@\'@^O;_ZU3*Y'!Y'ZBI:3W]V7Y^G?\S0MI(1U_7H?\#_
M )]JLA@?KW%4 0>E/5R/<?J/I_A4OM+1])=_7OZ[]S2,^C^__,O D=*E# ^Q
M]/\ #UJJL@/7\_\ 'TJ2HE&SOL^C6S_S1JG\U_6J?0L@D=/\_6I58'V/^>AJ
MJK]C^?\ C_C_ /KJ3Z5#2>CTET?1_P!=GJ:*7S7?JO5?JBXK]C^?^/\ C_\
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M'?\ Y!_7G'_'[17BXRWUBI;;W?\ TB)]=E6F H:W_B?^G9GY;:[_ ,AS6O\
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M*%M5JOQ_X)M&??1]^G]?@7U8'H<']14ROV/'OZ_X?RK-5R/<?J*LK(#U_/\
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M56!]C_/Z4%1FGH]'^8ZBBB@L*0J#]>QI:* :OHR J1U_/M258J)D[CGV]/\
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M_P"NI*I)(#U/X]_Q_P _XU.K$>X_STK)IK<U3ZIEI7['\_\ &IE8CW'^>E5
M0>E/#$?3N*BS6L?FNC_R9K&:>CT?X,N@@]*_E[_X.?GC3X6?\$\WFA2XA3]O
M/P"\MO( T<\:^'=;,D,BGADE0%'!X*D@U_3XK \@\_K7P/\ M]?\$\/A'_P4
M0\/?!?PW\7/&'Q%\'V?P/^+VD?&7PS-\.K[PW8W&J>(M&L;NPMM.UQO$GAKQ
M+%+HTD5W(\T5A%87QD5#'?QKN5N7%T95\/5ITDO:244HR:BKJ=.3NW=+2+Z-
M/;J>EE>(I83'X;$5G)4J4IN;C%RE:5&O!6BFF_>J1V>BN^A_%G\4-2\1^$_&
M?[1O_! #18M:TZ'XV?\ !8OX=>(?",4=O,;#2OV8?B-=0^)Y();E $@328K/
MX/\ C=;=?W1BC\0:A&G!(^T/V&?&/P-^!G@;_@Y7N/BA\6OB7^SQ\%-%_:BM
MOAV/'GP06Q7XM>']!U'XL?'[P1X:\,_#*._L;ZTB\3>(;::Q\':?.T-J-,MM
M3N-2&K: MB==TW^D?Q+_ ,$I/V;O%/\ P4A\(_\ !3O4=2\>+\<?"'AJ#0[;
MPE#?^'!\,]4U6R\$:W\/-.\7ZMIDOAJ7Q)/XBTWPMK$-G9/#XG@T^&XT71KL
M6)EM7\[R*R_X(=_LBR>!?V_OASXH\1_%WQAX9_X*(?%"Q^+_ ,4H]6U_PQ:7
MW@#QOHWC;Q=\0?#^I?"J^T?PAITFDKH7B;Q=<7-K#XG3Q7%=VFG6>F:LNH:=
M/JEMJ'F+ XB-1R2IMPEB(4N:5HJ@Z%6-"+M9ZU*TU))IQ2B[VV^A>=8"K2C2
MG*M3]K3P-7$N%-.4L9'&8:>,G!RYH-JAA*;A*491G*<HJ+=[_P CWQ"^%7A?
M]E?XJ_\ !*7]H#]E/]B[]J#]CC2/&7[0OPJTFQ_:8^/?Q[TJ]^*O[5&E:_K/
M@N_OKOQ3\#_#/BC78? ECXAT/4+K4==-FNA^%=?TGQ3-X;.B7VG^28?W ^,7
MQ&T'_@DA_P %W/BA\;/&%\^B?LQ_\% OV3OB3\2M26YO6L?#]G\;_@AX;N?&
M>OV%I)</Y#>(]<OO!)%E'AS<Z[\>+>R@3S)XHE^IIO\ @W7^"'BGP_\ ".T^
M*W[9_P"W-\6O%O[/FO\ @V_^ ?BOQG\4_#FJV?P>\,^!Y(9])\%^"?!&J^#=
M6\'V>E7]QI_AU]=U"ZTR[UFZM_"7AG3-,O=&TG3Y;"[^&/\ @X-NI?\ @HI\
M6_@+_P $TO@+^SA\=/%/[2OPZ_: \-ZGK_QQO_ASJ5C\'/A]\-/'7P^LYO$^
MI0>-87NK35?#5[#X@\+:[XFU.9=+T_1I_AW>:<\]UJWV.TDREAZN%IU*CBJ=
M15</4P].+C+GJQINE4IJ%&/*O:*3VO>*3G-R4FNN.,P^/Q%&@JDJM&6&Q]#'
MUIJI!T\/.M'$4*[J8JISS5&5./;EG*4:5&,'"+^W_P#@VR^#'B^T_9/^+/[;
MOQ;%S=?&+_@H%\<?&OQHUF_O'G:X'@?2_$?B'3_#$"17#.\%OJ'BO4?B)XIL
M60I'=Z+XBT614,4,#G].?^"B'[;/[,__  3Y^"4O[2OQ^T[2]=U[1KQ]"^#O
MA&RTW2;[XC^/?B#?6=TVG^$_ <]];RW.E//#]IN-?UY&CL= T,7M]=_:9GM-
M.U#ZL^#GPN\)? _X3?#/X,> K)=-\%?"CP%X2^'7A2R"HK0>'_!NA6/A_2A+
MY:JLEP]GI\4EU-C=/<O+-(6>1F/YA_\ !2[_ ((Q_ S_ (*B^._A9XX^-GQJ
M_:#\"CX/^&M4T#P=X8^%6O>!M,\.6MYKNLQZOK7BAX/%'@/Q5?)XCU06.A:?
M=7EI?6L)L?#ND(ELLT$DTO=[*I2PL:=",95XPBO?DE%SD^:I4;DFG[TIR7=\
MJ=M3Q%B<-BLSGB,9.I1PM2K*5Z,92DJ,%R4:$5!IPO3A2IM[1CSM)OE/F3_@
MD3^R!^U+\1?VF/C7_P %@?V_= @^'?[0/[1_@VS\!?!7X V]M<V,OP1^!N[0
MI;"'Q+I]XJW>F^)]1TOPSX<T^PTF_2/Q#IUBOB'6/%ZP^)O&-_HWA[^C17['
M\_\ '_'_ /77X3_LE_\ !$+X-_L1_$#QC\9?"7[2W[:OQFU?5/A+\0_A[/X*
M^)/Q*\(>)=-O+#QAIT"7MYHFGP^$/#$9\81"Q6+P[=:AJ\6GP7MR6O!Y9\Z+
MV[_@B[^RA\0?V./V*;/X9?$BR\9:'J?B3XN_%GXF>'/"'Q(\1Z+XM^)?@?X=
M^+O$>SX<>%OB5KWAAY/"E[\0;7P5I6B7WC./PL1H-CXBU'4-/L406LB+&'4Z
M2A1J46N;VLZDW4C4ESWB^>4HPC%NJY.R5E%044K*ZVQTZ.(E5Q%/%1DJ?U:C
M1I*A.A!4N6HE3IPG5J34</&$4YN_M'4<Y24FXOM/^"G'_!0+]GO_ ()O_"_1
MOC1X_P#!UE\1_CUXMNKSP/\ LX?"OP_IMC<_%#XG>-+J%+8Z+H6HI87^LZ)X
M3L&U>U7Q=KMM!=165OJUII5CI^K^(O$&A:%J_P"'/A+]@?\ :J\(?L!?\%AO
M^"C7[:'E6?[<'[<?[)OQ<N=0^&6@VSP1_!;X,Z5X O=2M_ %S;Q3W$T&OW?A
M[1=#TV]\/RWNJW/A;P]X.\-:3JFIW?B>7Q1%#^HO_!1/_@AK\!/^"E/QY\(_
MM ?&'X_?M,^!O$7@'P5HO@GP5X>^%7B?P'HWAGPS;:/KNK^)/[<T>+7_ (?>
M)-5LO$FI:OK#7.HZM!JB2S#3](CC6)--MMG6?L'?\$7O@C^PAX\^)'C?0OC[
M^T[\?K;XH_"O6?A%XF\$?M$^.?#GCCP._AG7]9T/5]5FBT+3?!^@))J-W'H:
MZ1++>37=NVD:CJEF;<B[=AG4HUZM>3E3C[!*<:4HU(+EE.G.$JU2"CS2G[W+
M"/,E&-W=R=UU4,3@\/A(*G6G];E*E4Q,)8>H_:0I5Z=6&$I5G4]G3I7I\]2?
M))U)J*]V$;/^:K]H75_#3?\ !H1^RO##=:?YT_Q7TO2K*-6B\QO$EK^T;\:K
MW5K6)0=PU!+&SUFYN$QYIMDN)"#&6:OZ0_C]^R#\#_&7_!/^+]HOXQ_"/PWX
MO_:6^"7_  2]\:>#/!_CGQ=:W6K:GX NV_9TU6_UZ?0=(U&YGT/2_$G]NR7C
M+XE72V\2V :6UL=5M8)KB*;YR\*?\&T'[%/AGXG>&]6NOBW^T_XK_9P\$_$U
M_C!X-_8O\5_$R'6/V>M%\<R.KM-+HT^C_P!JZCI!1193Q7%\OB'5M(4:1XB\
M3ZWI\]_#>_O;\6_AQHWQC^$WQ/\ @]XBO-2TWP]\5?AWXU^&NN:AHKVL.L:?
MHWCGPUJ?A?4[S29+VUO;./4K2RU2:>P>[LKNVCNHXFGM;B(-"\4</42FZL()
M_5Z5"$>934G1C4M4^%*-Y2CRIIRCJVTTB\7CJ#E16&JU6OKN)QE6;A*E*,,5
M4H-T+<[<^6%.:J--0F^6*339^&G_  ;B^(=,\(_\$0/@CXKUN*:;1O#$W[37
MB'5X;>W^UW$VF:+\:/B?J5_%!:G N9I+6VE2*WS^^<K'_%7\R'A']G[]H_X\
M_P#!*C]M7]M/X%_&?2?V?O\ @GE_PT#XJ^)US_P3%L]<\5:SX/\ $7@WP3XG
M\#WWBK0+_P"+(UJR\4^$YM4F@LY;3PEHUM%I^MW&F6-Q:MH@N=$2U_N[_82_
M8G^&?[ 7[+G@G]D[X7^(/&/C7X?^![SQK>6&K_$>?0=1\2ZC_P )UXNUSQCJ
MUOJLGA_0?#NBSV\-]K]W9VL<.C0?Z!'#'<FXF\V:3\B_%_\ P;._LC:UX@\:
MZ'X*_:(_;!^$/[,/Q,\<6WQ!^(7['7PY^*]KIGP(U[7K2\M[VWMX-%O-"OI[
M?28'M+.*RCU(ZWJ^E6]G80Z/K6G+IFDFPBKA:LJ.&ARJ3IT)TY1514VJDH1C
M&7/9\].+3YZ>T]&XRV6^'S'"PQ6.JRG*$:^,IUZ4Y4'64J,*U2I*'LG+]U7D
MI+V=;65)W2G!^\_U^_X)[?%WP-\>/V'/V4_BS\-/ $7PH\!^+_@9\/I_"_PQ
MMII+JQ^'VE:7H%IH47@S2[V6*"74=&\-OI<FD:-J<L%O+J>E6EG?RP0/<M$G
MV-7"_#CX>^"OA%X \%?"WX;>'-/\(?#[X=>%M"\%>"O"VE)(FF^'_"_AK3;;
M2-$TFS$TDT[PV.GVEO LUS-/=3E#-<SS3R22OW(8'Z]Q79&,X1C=IM1BI-*R
M;44GIT5T[>5MMCQJDDZE244U3E4G*%WS2C&4Y2BIO6[46DY7=W=MMN[6GJY'
M!Y'\J916BDI:/?\ K;^OO$6 0>E%0 D=/\_6I0P/L?2HE%K;5?EZ@.HHHJ0)
M%?L?S_QJ2J].#%?IZ4%QG;1[=^O_  2:BD!!Z4M W%/6/_ ?^0]7QP>??N/\
M:E!SR*KTH8CI^7:@2DUI+_@K_,GHI P/U[BEH-4[ZH**** &LH/L?Y_6HB".
M#4](0",&@B4$]5H_S(**<RD<]1_GK3:"5)QT>W];#64'V/K_ (^M1$$=:GH(
M!ZT%.*DKK?\ K?\ K[RO13V0CD<C]13*#-IK1A3&0'D<'T[?_6I]%--K5"*Y
M&.#14Y /6HF4K]/6M$U)6>_];?U]X#::R@].#_/Z_P"-.HJ7%Q=UM_6_]?<)
MJ^JT??\ S[D!!'!I*G(!ZU$RD?3U_P :N,D]'H_S]"6D]'I+H^C_ *[/480"
M,&HF4CGJ/\]:FHJC-IK<[SP#_P Q;_MP_P#;RBG^! !_:N._V'_V\HKQ\5_'
MJ?\ ;O\ Z1$^IRW_ '*C_P!Q/_3LS\I==_Y#FM?]A?4__2V>IXV!51WVC\>!
MR*@UW_D.:U_V%]3_ /2V>HT8J%],#_(->YP-_&S+_KUAO_3M4^,\9/\ =<@_
M["<P_P#4?#&@"0<BI58'CH?\]*J)(#U/X]_Q_P _XU+7Z$XI^O<_"E+OOT:W
M^?=%BG!B/<>G^'I4*OV/Y_X_YS4E9ZQT:NOP?IV9HI=_D^C]/\F6DDSUY_F/
MKZ__ *^M3JQ'0Y'\ZS@<<BIDDQUX_D?\#_GVHM?6.O==5_GZHUC.VCU7?JO\
MS1# ]/R[TX,1]/2JJMGD<$?Y_&IE?L>/?U_P_E4M7W-HRMJG=?@6@P/U[BG
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MG@D=/\_6JBN#CU_SR*F5^Q_/_&LFK:-&B;6W_ 9:5@?8_P">G^<U,K]C^?\
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M_P _I_A3JKT]7(X/(]>__P!>@(SZ2^__ #):* <\BB@T"BBB@"-D[C\O\/\
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M/\#12[:KMU7IW7XEBI%?L?S_ ,:A# ^Q]*=2::W+33V+%%0AB/<>E2@@]/\
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M'K2T4#4T])?\!_Y?UL0LI'N/7_'TIM6*C9.X_+_"@4H=5]W^7<[CP3_S$_\
MMR_]NZ*/!/\ S$_^W+_V[HKQ\5_'J?\ ;O\ Z1$^GRW_ '*C_P!Q/_3LS\F-
M=_Y#FM?]A?4__2V>L97['\_\:V==_P"0YK7_ &%]3_\ 2V>L*OJ. OXV9_\
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MB.O(_E]/\*E5NX/^?<5E*%M5JNW7_@FZ?5/[B\K ^Q_STJ=)".I_'M^/^?\
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M+C)/R?86BBB@H*8R9Y''MZ_X4^B@32>C.P\&C']I _\ 3G_[=45)X0_YB/\
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ME.)7VZ#75.4[/_RF>6!@?KW%+7J7_",Z'_SY?^3-Y_\ )%3CPSH9 _T+L/\
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M.AR/YUW/]A:5_P ^O_D>Y_\ CU/30]+R!]EX.?\ EO<^G_7:LOK5/M/[E_\
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>,Q$E*M.2O9\N_E%(^BP-.2PM)77V^_\ S\EY'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>eximg_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 eximg_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  @ K\# 2(  A$! Q$!_\0
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M8_VH];O[R2VLG^%'AK5=?\/>$_"7@[QOIK[KN'QOXG\4S_$/08M*A5!I=_\
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MKKBH3XB^)_;XB>.Q_P!S1K!'_I3_ %KV!M C/1?TX_ES^)J,^'HS_ I^H_\
MK5JL9A]GAL,M?^@7#?\ S.<TLKQRVQV8_P#APQ]O_4\\A/B/XHC_ )J'X]_\
M*;5S_*ZJ)O$WQ2'_ #43QU_X4^L?_)7)_"O7W\.I_<7'X8_(J"341\.QXX1?
M^^1G\.E7];P^C^K85KRPN&;_ /4<S>5X][8_,OEF&8-?^IZ1Y ?%7Q2'_-0_
M'0^OB?5__DL5&?%?Q3_Z*)XY'O\ \)/K!'_I3_6O7CX:0]8U_(4P^&E[1_B
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M]FO_ .$F*7X*C^I]S^5#_?'Y"CR(O7/UR!_6OAG_ (;C^'G_ $"-=_\ )?\
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M#Z3_ /<B$\3EK_Y^?^$F+_\ F?4^JSH<78+^(Q^H/%0G0HNR_D/\?ZU\M?\
M#=/PP_Z &O\ YVO^-)_PW1\,?^@#X@_.TI\F)M;W/_!U'_Y8+V^6=ZOI]3Q:
M_P#<!]1'P^A/W?S'_P!;CZ4T^'8^R)^(Q_[*:^7O^&Y_AA_T O$/_?5K_C2?
M\-S?"\]=!\0'_@5K_C0HXI?R_P#@^D__ '(0ZN6/_G[\\)BW_P"X#Z<;P['G
ME%_$ _R'%?+G[7FDK8_!V\F  SX@T*/A0/O33-R>I^Y]*F_X;E^&'_0!U_\
M\E?_ (JO#/VB/VG_  +\4?AO=>&-'L-5L+W^U]*U%9KT0>0T=I*ZR1DQD%78
M3[E)X.PKU85O0=>-6$IN*@E-2_?4GHZ=6.RG*3NY1223=VCDQDL#/#584%5E
=6?L^1?5<1!75>A)WE.C&,4HQFVY2223N^_\ _]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
